Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Repligen Corporation

Market Cap 7.53B 6.57B 6.06B 5.71B 10.65B 711B 10.74B 72.13B 27.95B 350B 28.27B 27.67B 1,215B P/E 2026 *
121x
P/E 2027 * 73.5x
Enterprise Value 7.28B 6.35B 5.85B 5.51B 10.29B 687B 10.37B 69.7B 27.01B 338B 27.32B 26.73B 1,174B EV / Sales 2026 *
8.84x
EV / Sales 2027 * 7.51x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day-1.15%
1 week+0.96%
Current month+6.51%
1 month+28.34%
3 months+10.69%
6 months-15.87%
Current year-19.43%
1 week 127.48
Extreme 127.48
136.54
1 month 103.5
Extreme 103.5
136.54
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 21.45
Extreme 21.45
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
14/05Free

Director

3,234 0.0057%
14/05Free

Director

3,234 0.0057%
14/05Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%+0.96%+9.10%-16.16% 7.53B
-0.10%-0.85%-33.16%-16.75% 154B
+1.54%-1.13%-7.93%-11.00% 100B
+3.24%+10.91%+72.09%+62.85% 57.66B
-1.90%-3.35%-7.29%+48.53% 53.91B
+1.67%-2.58%-15.28%-44.33% 39.02B
-1.32%-1.64% - - 30.8B
+1.74%-3.08%-11.44%-44.30% 27.49B
+1.35%-0.90%+50.39%-9.42% 22.86B
+0.58%-2.14%-12.73%-2.31% 20.68B
Average +0.60%-0.66%+4.86%-3.65% 51.44B
Weighted average by Cap. +0.73%-0.57%-4.34%-1.61%

Financials

2026 *2027 *
Net sales 823M 718M 662M 623M 1.16B 77.63B 1.17B 7.88B 3.05B 38.2B 3.09B 3.02B 133B 945M 825M 760M 716M 1.34B 89.14B 1.35B 9.05B 3.51B 43.86B 3.55B 3.47B 152B
Net income 61.09M 53.31M 49.13M 46.27M 86.33M 5.76B 87.06M 585M 227M 2.84B 229M 224M 9.86B 101M 88.28M 81.37M 76.63M 143M 9.54B 144M 969M 375M 4.7B 380M 372M 16.32B
Net Debt -254M -222M -205M -193M -360M -24B -363M -2.44B -944M -11.81B -955M -934M -41.05B -432M -377M -347M -327M -610M -40.74B -615M -4.14B -1.6B -20.04B -1.62B -1.59B -69.67B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
18/06/26 131.98 $ -1.18% 1,236,220
17/06/26 133.55 $ +1.41% 1,352,544
16/06/26 131.69 $ +0.63% 612,354
15/06/26 130.87 $ +0.21% 633,247
12/06/26 130.59 $ -2.06% 1,338,022
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
133.55USD
Average target price
176.11USD
Spread / Average Target
+31.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!